Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

The brand, which has been in existence for more than 60 years, is facing pressure from the rise of drugs like Ozempic.

Novo Nordisk will pay as much as $2 billion for a new obesity drug called UBT251 ... Nordisk works to expand its lineup of advanced weight-loss treatments. Although the company’s drugs have ...

Another major company is feeling the heat of changing trends — this time it’s Weight Watchers, the iconic diet and wellness ...

For decades, this company was the trusted companion in countless weight loss journeys. Its structured approach, points-based ...

(Gray News) – WeightWatchers is preparing to file for bankruptcy, according to a new report from the Wall Street Journal. The ...

Weight Watchers is preparing to file for bankruptcy amid rising competition from weight-loss drugs. Get all the info and what ...

Early in 2024, WeightWatchers lost its most prominent board member, Oprah Winfrey, when the media mogul announced her ...

WeightWatchers bankruptcy looms as the company struggles with debt and competition from weight-loss drugs like Ozempic. Can ...